Institute of Tropical Medicine (ITM), Department of Clinical Sciences, Central Laboratory for Clinical Biology (CLKB), Kronenburgstraat 43/3, B-2000 Antwerp, Belgium.
Robert Koch Institute (RKI), Center for Biological Threats and Special Pathogens (ZBS-1), Nordufer 20, 13353 Berlin, Germany.
J Clin Virol. 2014 Dec;61(4):597-9. doi: 10.1016/j.jcv.2014.10.008. Epub 2014 Oct 22.
We report a dengue virus (DENV) co-infection in a Belgian traveler after a three-weeks holiday to Thailand. The patient recovered well without any complication. The infection was diagnosed by NS1 antigen testing and the concurrent presence of serotype DENV1 and DENV2 was demonstrated by reverse transcriptase polymerase chain reaction (RT-PCR) in acute phase serum sampled three days after symptoms onset. The predominant DENV1 serotype was identified as genotype I, lineage Asia-3 by sequencing. To our knowledge, this is the first time that a dengue co-infection is reported in a European traveler. The co-infection accounts for 1.0% of the total number of RT-PCR-positive samples (n=105) diagnosed in the reference laboratory of Belgium between 2008 and 2013. We expect that the number of reports on acute co-infections will increase in the coming years considering the increasing number of regions that are progressively becoming hyperendemic, especially in Southeast Asia.
我们报告了一例在泰国旅行三周后出现的登革热病毒(DENV)合并感染的比利时旅行者病例。该患者无并发症,康复良好。感染通过 NS1 抗原检测诊断,在症状出现后三天采集的急性期血清中通过逆转录聚合酶链反应(RT-PCR)同时检测到血清型 DENV1 和 DENV2,表明合并感染。通过测序,确定主要的 DENV1 血清型为基因型 I,亚洲-3 谱系。据我们所知,这是首次在欧洲旅行者中报告登革热合并感染。在 2008 年至 2013 年期间,比利时参考实验室诊断的 105 例 RT-PCR 阳性样本中,合并感染占总数的 1.0%。考虑到越来越多的地区逐渐变得高度流行,尤其是在东南亚,我们预计未来几年急性合并感染的报告数量将会增加。